Geoff Dusheiko

King's College Hospital — United Kingdom

Medicine · Health Sciences

16h-index2.8kcitations35works4.52yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hepatitis C virus research(30), Hepatitis B Virus Studies(26), Liver Disease Diagnosis and Treatment(12), HIV/AIDS drug development and treatment(6), Immune Cell Function and Interaction(4)

Publications35 total

P166 Semi-qualitative feedback from individuals living with HBV newly diagnosed in the emergency department ED opt-out testing program high acceptability but better platforms of advocacy and support required
2025
Prevalence of Drug Resistance Associated Substitutions in Persons With Chronic Hepatitis C Infection and Virological Failure Following Initial or Re-treatment With Pan-genotypic Direct-Acting Antivirals: A Systematic Review and Meta-analysis
Clinical Infectious Diseases·2024· 9 citedOpen Access
Prevalence of Drug Resistance Associated Substitutions in Hepatitis C-Infected Patients Whose WHO-Recommended Direct Acting Agents for Initial Treatment and Retreatment Fails: A Systematic Review and Meta-Analysis
SSRN Electronic Journal·2023Open Access
Universal versus targeted screening for <scp>HCV</scp> infection in pregnancy in a diverse, multi‐ethnic population: Universal screening is more comprehensive
Journal of Viral Hepatitis·2022· 6 cited
Prevalence of HIV/hepatitis B and HIV/hepatitis C coinfection among people of East, South, Central and West African ancestry in the United Kingdom
AIDS·2021· 4 citedOpen Access
Micro-elimination of HIV and HCV co-infection
The Lancet HIV·2020
High patient acceptability for a hepatitis C mobile outreach service targeting ‘vulnerable’ homeless communities - an important component for elimination?
Journal of Hepatology·2020· 3 citedOpen Access
Risk stratification in chronic hepatitis B patients for hepatocellular carcinoma surveillance: management in migrant sub-Saharan African populations
Gut·2020· 3 cited
Hepatitis delta genotype 5 is associated with favourable disease outcome and better response to treatment compared to genotype 1
Journal of Hepatology·2020· 59 citedOpen Access
Reply to: “Is resistance to direct-acting antivirals in sub-Saharan Africa a threat to HCV elimination? Recommendations for action”
Journal of Hepatology·2019· 3 citedOpen Access
Suboptimal SVR rates in African patients with atypical genotype 1 subtypes: Implications for global elimination of hepatitis C
Journal of Hepatology·2019· 73 citedOpen Access
PS-181-Unacceptably low SVR rates in African patients with unusual HCV sub-genotypes : Implications for global elimination
Journal of Hepatology·2019· 4 cited
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology &amp; Hepatology Commission
˜The œLancet. Gastroenterology & hepatology·2019· 530 citedOpen Access
Managing HBV in pregnancy. Prevention, prophylaxis, treatment and follow-up: position paper produced by Australian, UK and New Zealand key opinion leaders
Gut·2015· 71 citedOpen Access
Cost-Effectiveness Analysis of Alternative Antiviral Strategies for the Treatment of HBeAg-Positive and HBeAg-Negative Chronic Hepatitis B in the United Kingdom
Value in Health·2015· 25 cited
Telaprevir or boceprevir based therapy for chronic hepatitis C infection: Development of resistance-associated variants in treatment failure
Antiviral Research·2014· 12 cited
Mutations and the Development of Anti-viral Resistance
2011
Treatment of chronic hepatitis B virus infection in resource-constrained settings: expert panel consensus
Liver International·2010· 69 citedOpen Access
Cost–Utility Analysis of Tenofovir Disoproxil Fumarate in the Treatment of Chronic Hepatitis B
Value in Health·2010· 41 citedOpen Access
Lamivudine and Adefovir Resistance: What should we do?
2010
page 1 of 2Next →

Frequent Co-authors

Kosh Agarwal(8), Kate Childs(6), Paul Klenerman(4), Emma C. Thomson(4), Peter Simmonds(3), Olufunmilayo Lesi(3), Eleanor Barnes(3), Mary Cannon(3), Marco Vitória(3), Ivana Carey(3), Rachel Halford(3), Brian J. McMahon(2), Elizabeth Robinson(2), Ed Gane(2), Matthew Hickman(2), Ponsiano Ocama(2), Mark Thursz(2), David J. Brown(2), Anastasios Karadimitris(2), Stephan D. Gadola(2)